PACIRA BIOSCIENCES, INC. (PCRX) Gross margin 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) gross margin by fiscal year — reported gross profit divided by reported revenue.
79.4%FY2025 · since FY2016: 59.2% → 79.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 79.4% | +3.7 pp |
| FY2024 | 75.7% | +3.0 pp |
| FY2023 | 72.6% | +2.5 pp |
| FY2022 | 70.1% | -4.0 pp |
| FY2021 | 74.1% | +1.4 pp |
| FY2020 | 72.7% | -1.8 pp |
| FY2019 | 74.5% | +0.7 pp |
| FY2018 | 73.9% | +4.8 pp |
| FY2017 | 69.1% | +9.8 pp |
| FY2016 | 59.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice